Key facts
- The Trump administration is moving to ban a potent synthetic version of kratom.
- This policy is expected to benefit makers of rival botanical supplements.
- Homeland Security Secretary Markwayne Mullin has a financial investment in a kratom company, Botanic Tonics.
- The kratom industry has actively lobbied and made donations to influence policy.
- The FDA removed links to a legal case against Botanic Tonics following industry pressure.
- A federal case against Botanic Tonics was dropped by the Justice Department.
The Trump administration's decision to restrict a potent synthetic version of kratom is poised to benefit companies producing rival botanical supplements, according to reports. This policy shift is the result of an extensive influence campaign by the kratom industry, which has courted administration officials and utilized lobbying efforts.
Federal health officials have long raised concerns about kratom, citing risks such as liver toxicity, seizures, and links to thousands of deaths. However, figures close to President Donald Trump, including Homeland Security Secretary Markwayne Mullin, have reportedly worked to downplay these risks. Mullin himself disclosed an investment worth up to $1 million in Botanic Tonics, a company that stands to gain from the proposed restrictions on competing synthetic products.
Jerry W. Ross, the founder of Botanic Tonics and a key figure in the influence campaign, had previously pleaded guilty to a financial crime. The campaign involved donations and lobbying, with one industry executive stating that such efforts are essential for having a voice in government. The strategy has been to cast kratom products as aligned with the administration's 'Make America Healthy Again' agenda.
Further evidence of the industry's influence includes the FDA's deletion of links on its kratom webpage that detailed a pending legal case against Botanic Tonics. The company had been sued by the federal government for illegally selling unproven kratom products, but the Justice Department unexpectedly moved to drop the case in December, a development celebrated by the company.